Heart Failure Clinical Trial
Official title:
Palliative Care in Heart Failure (PAL-HF)
The primary aim of the PAL-HF trial is to assess the impact of an interdisciplinary palliative care intervention combined with usual heart failure management on health-related quality of life as measured by the Kansas City Cardiomyopathy Questionnaire and the Functional Assessment of Chronic Illness Therapy with Palliative Care Subscale.
Heart failure currently affects over 5 million Americans. Symptomatic patients have a median
life expectancy of less than 5 years and those with late-stage disease have 1-year mortality
rates approaching 90%. Despite recent therapeutic advances that reduce morbidity and
mortality, heart failure continues to cause enormous suffering. Patients with advanced
disease suffer not only from the physical effects of the illness, but also from psychosocial
and spiritual distress. In addition, heart failure costs more than $34 billion annually to
the healthcare system and a disproportionate amount is spent on patients in the last 6 months
of life when some of the treatments may be either ineffective or undesired. Selected patients
are candidates for aggressive treatments such as cardiac transplantation or mechanical
circulatory support, but the application of these therapies to the broader heart failure
population is limited by resource scarcity and their untested usefulness in older patients
with significant co-morbidities.
The progressive nature of heart failure coupled with high mortality rates and poor quality of
life mandates greater attention to palliative care as a routine component of heart failure
management. Patients with advanced heart failure, particularly the elderly and those with
significant co-morbidities, ought to be ideal candidates for palliative care that aims to
relieve suffering and improve quality of life. Yet, several challenges have limited the use
of palliative care approaches in heart failure:
1. Determination of Prognosis. Several validated multivariable models have been developed
to predict survival, yet considerable uncertainty remains and physicians are frequently
unsure whether they are caring for a patient near or far from the end of life. Patients
have an even harder time and are typically overly optimistic about their survival
relative to that observed or predicted by multivariable models.
2. Timing of Implementation. This prognostic uncertainty and the highly variable disease
trajectories of individual patients with heart failure pose a challenge as to when
palliative care interventions ought to be implemented. The most appropriate time to
introduce palliative care concepts, particularly with regard to end-of-life planning,
remains undefined and is linked to patient prognosis and preferences.
3. Untested Interventions. There is limited evidence from randomized controlled trials of
palliative care interventions in heart failure and the majority focus on resuscitation
preferences. Further, practice guidelines from major cardiovascular societies are
limited on this subject.
4. Lack of Palliative Care Training of Cardiovascular Specialists . The education of
cardiovascular specialists typically excludes formalized training in the principles and
practice of palliative care.
Given these limitations, a properly designed and powered study is required to determine
whether a multidimensional palliative care intervention in addition to usual care improves
health-related outcomes relative to usual care alone in advanced heart failure patients with
a highly probable short-term mortality.
PAL-HF is prospective, controlled, unblinded, 2-arm, single-center clinical trial of
approximately 200 advanced heart failure patients with >50% predicted 6-month mortality
randomized to usual, state of the art heart failure care or usual care combined with the
PAL-HF intervention.
Patients will be randomized in a 1:1 ratio to either of 2 treatment regimens:
- Usual advanced HF care
- Usual advanced HF care + interdisciplinary palliative care focused on symptom relief;
assessment and management of anxiety, depression, and spiritual concerns; as well as
advance care planning that includes definition of care goals, resuscitation preferences,
and participation in the Outlook intervention.
The primary endpoint will be health-related quality of life as measured by the Kansas City
Cardiomyopathy Questionnaire (KCCQ) and the Functional Assessment of Chronic Illness Therapy
with Palliative Care Subscale (FACIT-Pal) score at 6 months
The duration of the intervention in PAL-HF is 6 months, but patients in both groups will be
followed until death, or the end of the study.
The study will be completed in both arms of the trial with a post-death interview with the
caregiver.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|